Interpharma Burger
biotechlerncenter
datacenter
Shop Publications
Interpharma Burger schließen
biotechlerncenter
datacenter
Shop Publications
Anzeigebild EN
A strong economic framework
A strong economic framework
Pharmastandort 2030
11 september 2024

Georg Därendinger

Advanced Manufacturing in the Swiss pharmaceutical industry: innovation and efficiency
read moreread more
Lung-on-Chip: A Humane Solution for Testing Lung Function and Toxicity
Leading in research & development
Icon
Research

14 january 2025

Georg Därendinger

Lung-on-Chip: A Humane Solution for Testing Lung Function and Toxicity

read moreread more

Interactive map

Discover Interpharma member companies and their sites.

read moreread more
Blog Series with the 3RCC, part 9:Unlocking New Therapies: How Cutting-Edge Research Without Animals is Paving the Way for Fatty Liver Disease Treatments!
Leading in research & development
Icon
Animal experiments
Innovation
Research

7 november 2024

Georg Därendinger

Blog Series with the 3RCC, part 9:Unlocking New Therapies: How Cutting-Edge Research Without Animals is Paving the Way for Fatty Liver Disease Treatments!

read moreread more
A strong economic framework
Icon
Facts & Figures

5,4%

is the direct contribution of the pharmaceutical sector to the gross domestic product (GDP), making it one of Switzerland's most significant private-industry sectors.

Blog Series with the 3RCC, part 8: Do insects have emotions? New studies spark debate on the small invertebrate’s ability to feel pain 
Leading in research & development
Icon
Innovation
Research

23 october 2024

Georg Därendinger

Blog Series with the 3RCC, part 8: Do insects have emotions? New studies spark debate on the small invertebrate’s ability to feel pain 

read moreread more
Healthcare system
Icon
Messages

People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.

Blog Series with the 3RCC, part 7: New method recreates realistic tissue structures to advance cancer research
Leading in research & development
Icon
Research

9 october 2024

Georg Därendinger

Blog Series with the 3RCC, part 7: New method recreates realistic tissue structures to advance cancer research

read moreread more
Putting the focus on patients
Icon
Messages

Our mission is to ensure that patients in Switzerland receive access to innovative medicines and therapies as quickly as possible.

Leading in research & development
Icon
Publication

Animal Welfare Report

2019 edition

DownloadDownload

show more articles show more articles

Our topics

Icon Icon

Putting the focus on patients Icon

Our mission is to ensure that all patients in Switzerland receive the best possible medicines and therapies for their needs as quickly as possible as part of their basic health insurance cover. For this to happen, medicinal products need to be authorised promptly by Swissmedic, basic health insurance needs to cover products from day 1 of authorisation, and there need to be sustainable models to reward innovations. We ensure that these medicinal products and therapies are of the highest possible quality. And we play our part in making sure that the cost of these therapies remains commensurate with the benefit they offer for patients, society and the economy.

Topics

Recent publications

Pharma hub 2030

DownloadDownload

Pharma Market in Switzerland

DownloadDownload

Icon Icon

Leader in research and development Icon

Pharmacological and technological innovations will lead to rapid improvements in medicinal products. Digitalisation, in particular, will bring about a fundamental change in the way medicines are developed and used, enabling new approaches to be adopted in research. These will create great potential for medical progress and benefits for patients. A concerted effort by all players is needed in order to implement this potential.

Topics

Recent publications

Animal Welfare Report

DownloadDownload

Rare diseases

DownloadDownload

Icon Icon

A strong economic framework Icon

Switzerland and the pharmaceutical industry have been travelling a successful path together for decades. An economic policy that provides attractive framework conditions has favoured the impressive development of the research-based pharmaceutical industry. At the same time, the pharmaceutical industry is a pillar of the economy, contributing to Switzerland’s prosperity to an above-average degree. The pharmaceutical industry will continue to need optimum framework conditions in the future, and Switzerland needs successful companies. Political stability, legal certainty, open export markets, the availability of a qualified workforce and an attractive fiscal landscape are all factors that play a major role in this symbiosis.

Topics

Recent publications

Importance of the pharmaceutical industry in Switzerland

Icon Icon

Healthcare system Icon

Nowadays, we are living longer and better in Switzerland because the population is benefiting from innovative medicinal products and has access to high-quality healthcare. Yet there is a need for action and improvement in a number of areas, and there are new challenges that are in urgent need of solutions. These include, for example, promotion of a world-leading ecosystem for health data, flexible reimbursement models for innovations and more intensive cooperation with the authorities.

Topics

Recent publications

Health monitor 2019

DownloadDownload

Swiss Healthcare

DownloadDownload

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2023

read more read more

Board and Executive Management

Introducing Interpharma

read more read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more read more

Contact

Contact us

read more read more

Media

Latest information and media contacts for media representatives

read more read more